New Nestable Cart with Ultralife Power Launches at HIMSS

Innovative cart and power solution to be unveiled at IT healthcare show

Nestable Cart with Ultralife Power

Battery manufacturer Ultralife Corporation will join forces with cart manufacturer Karta to launch a complete medical cart and power solution on booth 1237 (Hall A) at HIMSS, from March 12-14, 2024 at the Orange County Convention Center in Orlando, Florida.

Developed specifically to use Ultralife’s X5 Power System, multiples of the new carts from Karta can be compactly nested together with their power systems attached, to reduce the amount of storage space by 35 per cent. Utilizing the X5’s output of 120VAC 60Hz, these innovative carts can power laptops, all in one systems, and mini PCs. This can be achieved by plugging the power system into AC mains or, when AC mains is not available or convenient, via. two external hot-swappable batteries (276Wh each).

High-Quality Aluminum

Both the cart and power system are built from high-quality aluminum, with Karta also having steel components, to ensure durability and ease-of-sterilization. The batteries can be removed from the power system with a single hand and can be connected in either orientation to ensure fast and smooth operation. The cart itself is equipped with adjustable height settings and high-quality castors for seamless mobility, alongside a range of customizable accessories to fit various clinical workflows.

Eric Lind, Senior Vice President of Sales at Ultralife

“For the past three years, the X5 Power System has proven to be really popular at HIMSS. Therefore, it seemed only natural that we should launch the complete cart and power solution at this year’s event. Visitors to our booth will also be able to discuss the X5-LITE Power Solution for pole/mobile carts that only require USB-C or USB-A power.”

Attendees can also learn more about Ultralife’s other medical power solutions, which include pre-engineered batteries for ventilators, x-ray, and imaging equipment, non-rechargeable cells for remote patient monitoring or asset tracking, as well custom battery design and manufacturing services for specialized needs.

HIMSS 2024 will run from March 12-14 at the Orange County Convention Center in Orlando, Florida. Visitors to the event can book a one-to-one appointment with an Ultralife representative using this form. Alternatively, to find out more information about Karta and the X5 power solutions, contact a member of the team on the Ultralife website.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.